Follow-The-Filings

Manager activity

Merck & Co., Inc.

2026 Q2 vs 2026 Q1 · filed 7 Aug · all filings · sitewide activity

New 3
Exit 4

7 shown

ticker action Δ weight detail period
TRDA New +2.43% opened 2.4% Q1→Q2
STRO New +1.72% opened 1.7% Q1→Q2
Evaxion Biotech New +0.71% opened 0.71% Q1→Q2
TRDA Exit −6.28% was 6.3% Q1→Q2
Sutro Biopharma Exit −1.94% was 1.9% Q1→Q2
Evaxion Biotech Exit −1.29% was 1.3% Q1→Q2
Carisma Therapeutics Exit −0.01% was 0.01% Q1→Q2